Some plans cover Semaglutide fully for diabetes indications while excluding weight management
If I remember rightly I recall it happening in my right arm over ten years ago
Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomized, double-blind, double-dummy, placebo-controlled, phase 3 trial
That said, patients need to know what to expect and how to respond
Often this is not apparent immediately, but the problems will manifest themselves over time
People are more likely to experience nausea and vomiting on Ozempic than Saxenda, which might explain why liraglutide users are more likely to stop treatment because of side effects than those on semaglutide